Periodic Reporting for period 2 - AI-Mind (Intelligent digital tools for screening of brain connectivity and dementia risk estimation in people affected by mild cognitive impairment.)
Reporting period: 2022-03-01 to 2023-08-31
Notably, AI-Mind has received an invitation to exhibit at the NEMO Science Museum in Amsterdam for the entirety of 2024, exceeding the project's initial expectations. Additionally, the project has established itself within the European Strategy Forum on Research Infrastructures (ESFRI) EBRAINS and is actively pursuing new EU and national research applications in collaboration with EBRAINS partners. Several publications have been submitted during this reporting period, including a scientific paper describing the background, methods, and clinical study protocol of the AI-Mind project. The project has made significant progress in various areas, including data management, algorithm and AI concept development, infrastructure enhancement, clinical validation, and dissemination activities. Future reports will focus on innovation, intellectual property rights, public relations, and the exploitation of project results in collaboration with new industrial partners, ultimately aiming to achieve a groundbreaking clinical breakthrough using the diagnostic tool for predicting future dementia risk in individuals with mild cognitive impairment.
Moreover, establishing a robust reference database within Europe is crucial to support future public-private AI health strategy, and will contribute to the integration of reliable AI tools into our healthcare systems. Through collaboration with EBRAINS, eBRAINS Health, and various industrial partners, AI-Mind is better positioned in its second report period to recognize and assess the considerable socioeconomic implications that the implementation of its tools may have for the European Union.